Grifols SA SEC filings GRFS

Grifols SA has 463 filings in SEC EDGAR's recent list, going back to Oct 20, 2008. Its latest annual report, Form 20-F, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026.

Form Description Filed Period
20-F Annual report (foreign issuer) Apr 17, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Apr 11, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Apr 19, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Apr 18, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Apr 29, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Apr 9, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Apr 6, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) Apr 23, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Apr 5, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Apr 6, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Apr 4, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Apr 5, 2016 Dec 31, 2015
20-F Annual report (foreign issuer) Apr 1, 2015 Dec 31, 2014
20-F Annual report (foreign issuer) Apr 4, 2014 Dec 31, 2013
20-F Annual report (foreign issuer) Apr 5, 2013 Dec 31, 2012
20-F Annual report (foreign issuer) Mar 29, 2012 Dec 31, 2011
20-F Annual report (foreign issuer) Apr 7, 2011 Dec 31, 2010

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GRFS (Nasdaq), GIFLF (OTC), GIFOF (OTC), GIKLY (OTC)
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1438569

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.